Here, for the first time, the arylesterase and paraoxonase activities of PON-1 were evaluated, as well as the frequency of the polymorphism in PON-1, PON-2, and PON-3 genes, in patients with sickle cell disease. This evidence concerns the gene PON2 and sickle cell disease.